Antipsychotic Treatment and Tobacco Craving in People With Schizophrenia.
Antipsychotic Treatment and Tobacco Craving in People With Schizophrenia.
复制标题
精神分裂症患者的抗精神病治疗和烟草渴望。
DOI：
10.1080/15504263.2017.1288946
复制
发表时间：
2017
影响因子：
2.2
通讯作者：
Kelly,DeannaL
中科院分区：
文献类型：
--
作者：
Wehring,HeidiJ;Heishman,StephenJ;McMahon,RobertP;Liu,Fang;Feldman,Stephanie;Raley,Heather;Weiner,Elaine;Kelly,DeannaL
目的：尼古丁依赖是高精神分裂症，和渴望是众所周知的影响复发戒烟attempts.Methods：我们比较了吸烟者与精神分裂症治疗不同的抗精神病药物治疗的烟草渴望。结果：平均渴望得分最低的参与者接受第一代抗精神病药物，虽然这些差异没有统计学意义。氯氮平的渴求并不低于其他抗精神病药物。结论：需要进一步的研究，以确定是否存在抗精神病药物类之间的渴求差异。
Objective: Nicotine dependence is high in schizophrenia, and craving is known to impact relapse during quit attempts.Methods: We compared tobacco craving in smokers with schizophrenia treated with different antipsychotics.Results: Mean craving scores were lowest in participants receiving first-generation antipsychotics, although these differences were not statistically significant. Craving with clozapine was not lower than with other antipsychotics.Conclusions: Further research is needed to determine whether differences in craving exist between antipsychotic classes.